The Centers for Disease Control and Prevention estimate about one in 59 children have autism spectrum disorder (ASD). As more children and adults are diagnosed, there is a great need for research to help us further understand the complexities of ASD and effective treatments.
The AARTS Center at Rush is dedicated to leading these research efforts in the Chicago area.
Some of the studies currently offered through the AARTS Center at Rush include the following:
Autism spectrum disorder
SPARK: Simons Foundation Powering Autism Research for Knowledge
Ages: all ages
Study coordinator: Holly Lechniak, (312) 563-2765 or email: firstname.lastname@example.org
ION: Study of Social Skills Groups for Children with Autism Spectrum Disorder (ASD)
Ages: 8-11 years
Study coordinator: Sarely Licona, (312) 942-6331 or email: Sarely_Licona@rush.edu
Mirror Me: Expanding Access to Early Intervention for ASD
Ages: 18 to 60 months
Study coordinator: ZSarely Licona, (312) 942-6331 or email: Sarely_Licona@rush.edu
The Av1ation Study: a Clinical Trial for Children and Adolescents with ASD (CLOSED TO ENROLLMENT)
Ages 5-17 years
Study coordinator: Madison Printen, (312) 563-3352 or email: email@example.com
Ages 18 and upStudy coordinator: Linda Skaggs, (312) 942-5592 or email: Linda_Skaggs@rush.edu
Our mission is to explore, build and develop treatments for undertreated needs (e.g., social impairments, attention challenges) of children, teenagers and adults with ASD.
Researchers and clinicians at the center are dedicated to testing those treatments, and, ultimately, sharing them with the community at large.
Research programs at the AARTS Center at Rush focus on the following areas:
- Biological and genetic factors: Through collaborations with local and national ASD leaders, the AARTS Center at Rush facilitates research on causes of ASD. Research on biological and genetic factors associated with ASD may help personalize treatment approaches.
- Combination treatments: Studies that investigate combining medications, education, behavioral and psychological treatments to address the complexities of ASD.
- Clinical trials: Research that evaluates new initiatives, including novel medications, devices and technology to improve the diagnosis and treatment of ASD.
- Services and implementation research: Studies and research programs designed to modify and adapt ASD treatments interventions to make them suitable for community or education settings.
Why participate in research?
For patients and families
Participating in studies offers individuals and families living with ASD the opportunity to do the following:
- Participate in innovative treatments
- Receive evaluations of individual strengths and weaknesses
- Contribut to the autism community by helping researchers learn more about the diversity and complexities of ASD — which could, ultimately, lead to more tailored treatments for individuals with ASD
For referring physicians
Referring physicians within Rush University Medical Center and at other institutions can refer patients for clinical trials and research studies at the AARTS Center at Rush. Some of the benefits of referring your patients to these studies include the following:
- Offering your patients expert care and novel treatments
- Opportunities to collaborate with leading researchers and clinicians in the field